Journals / Turkish Journal of Rheumatology(.)Archives of Rheumatology / 2012 / Cilt: 27 - Sayı: 3

Behçet Hastalığında Hormon Düzeylerinin Değerlendirilmesi

An Evaluation of Hormone Levels in Behçet's Disease

Pages
158–164
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, further, large-scale studies are needed to evaluate the correlations between PRL, GH, and DHEAS values and ocular involvement

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aims to evaluate the basal serum levels of the hypophysial, thyroidal, adrenal, and gonadal hormones and the disease activity in patients with Behçet's disease (BD).
📊
Key Findings & Data:Patients and methods: Forty-three patients (22 males, 21 females; mean age 34 years; range 21 to 46 years) were divided into the following four groups according to the disease activity and presence of ocular involvement: Active BD (n=27), inactive BD (n=16), those with ocular involvement (n=14), and those without ocular involvement (n=29).
💡
Conclusion & Impact:Also, further, large-scale studies are needed to evaluate the correlations between PRL, GH, and DHEAS values and ocular involvement
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This study aims to evaluate the basal serum levels of the hypophysial, thyroidal, adrenal, and gonadal hormones and the disease activity in patients with Behçet's disease (BD). Patients and methods: Forty-three patients (22 males, 21 females; mean age 34 years; range 21 to 46 years) were divided into the following four groups according to the disease activity and presence of ocular involvement: Active BD (n=27), inactive BD (n=16), those with ocular involvement (n=14), and those without ocular involvement (n=29). A group of 40 (18 male, 22 female) healthy subjects matched according to age and gender were used as the negative control group. A positive control group (two males and 14 females) consisted of 16 patients with systemic lupus erythematosus. Triiodothyronin, thyroxin, the thyroid-stimulating hormone, the follicle- stimulating hormone, the luteinizing hormone, the growth hormone (GH), dihydroepiandrosterone sulphate (DHEAS), estradiol, testosterone, basal cortisol, prolactin (PRL), and the adrenocorticotropic hormone were evaluated in all subjects. Results: No clinically significant differences were found between the BD groups and negative control group in terms of the basal serum levels of the hypophysial, thyroidal, adrenal, and gonadal hormones. When the hormonal values were evaluated with regard to disease activity and ocular involvement, the BD patients with ocular involvement showed significantly higher PRL and GH values in both genders and significantly lower DHEAS levels in female patients. Conclusion: Despite being a vasculitis-related disease, we can conclude that BD has no major influence on the endocrine system. Also, further, large-scale studies are needed to evaluate the correlations between PRL, GH, and DHEAS values and ocular involvement

Özet

Bu çalışmada, Behçet hastalığında (BH) hipofizyal, tiroidal, adrenal ve gonadal hormonların bazal serum düzeyleri ile bu hormonların hastalık aktivitesi arasındaki ilişkileri değerlendirildi.Hastalar ve yöntemler: Kırk üç hasta (22 erkek, 21 kadın; ort. yaş 34 yıl; dağılım 21-46 yıl), hastalık aktivitesi ve oküler tutulum varlığına göre dört gruba ayrılarak değerlendirildi: Aktif BH (n=27), inaktif BH (n=16); oküler tutulum (n=14) ve oküler tutulum olmayanlar (n=29). Negatif kontrol grubu olarak benzer yaş ve cinsiyette 40 sağlıklı birey (18 erkek, 22 kadın) değerlendirmeye alındı. Pozitif kontrol grubuna ise 16 (2 erkek, 14 kadın) sistemik lupus eritematozus hastası dahil edildi. Çalışmaya alınan tüm bireylerde triiyodotironin, tiroksin, tiroid stimüle edici hormon, follikül stimüle edici hormon, lüteinize edici hormon, büyüme hormonu (GH), dihidroepiandrosteron sülfat (DHEAS), östradiol, testosteron, bazal kortizol, prolaktin (PRL) ve adrenokortikotropik hormon düzeyleri değerlendirildi.Bulgular: Negatif kontrol grubu ile BH grupları arasında, hipofizyal, tiroidal, adrenal ve gonadal hormonların bazal serum düzeylerine göre klinik bulgularda herhangi bir anlamlı değişiklik saptanmadı. Hormon düzeyleri ile hastalık aktivitesi ve oküler tutulum ilişkisine bakıldığında ise, oküler tutulumu olan her iki cinsiyetteki BH hastalarında PRL ve GH değerlerinin anlamlı yüksek, kadın hastalarda ise DHEAS seviyelerinin anlamlı düşük olduğu bulundu.Sonuç: Vaskülitik bir hastalık olmasına karşın BH'nin endokrinolojik sisteme majör bir etkisi olmadığı söylenebilir. Bununla birlikte, PRL, GH ve DHEAS düzeyleri ile oküler tutulumu olan BH arasında saptanmış olan ilişkinin irdelenmesi için geniş ölçekli çalışmalara gereksinim vardır

🔖

Cite This Article

KARAKUŞ, S., NAR, A., TOPRAK, S. K., ATALAY, F., ÖZCEBE, O. İ. (2012). Behçet Hastalığında Hormon Düzeylerinin Değerlendirilmesi. Turkish Journal of Rheumatology(.)Archives of Rheumatology, Cilt: 27 - Sayı: 3, 158–164. https://ajindex.com/articles/375951

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
  2. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behçet's disease. Clin Exp Rheumatol 1995;13:687-91. Kastner DL. Behçet's disease. In: Koopman WJ, editor. Arthitis and allied conditions. A textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams Willkins; 2001. p. 1420-29.
  3. Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000;26:713-36.
  4. Atasoy M, Karatay S, Yildirim K, Kadi M, Erdem T, Senel K. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease. Cell Biochem Funct 2006;24:353-6.
  5. Colak R, Ozkan Y, Cengiz SU, Saral Y, Kandi BC, Halifeoglu I. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease. J Eur Acad Dermatol Venereol 2006;20:721-5. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
  6. Onder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001;15:126-36.
  7. Chrousos GP, Elenkov IJ. Interactions of the endocrine and immune systems. In: De Groot LJ, Jameson JL, editors. Endocrinology. 4th ed. Philadelphia: Saunders; 2001. p. 571-86. Ohguchi M. Endocrinological examinations in Behçet's disease (author's transl). Nihon Ganka Gakkai Zasshi 1979;83:1486-93. [Abstract] Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991;26:118-23.
  8. Proença H, Ferreira C, Miranda M, Castanheira-Dinis A, Monteiro-Grillo M. Serum prolactin levels and Behçet disease. Eur J Ophthalmol 2007;17:404-7.
  9. Houman H, Ben Ghorbel I, Lamloum M, Feki M, Khanfir M, Mebazaa A, et al. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity. Ann Med Interne (Paris) 2001;152:209-11.
  10. Keser G, Oksel F, Ozgen G, Aksu K, Doganavsargil E. Serum prolactin levels in Behçet's Syndrome. Clin Rheumatol 1999;18:351-2.
  11. Aksu K, Oksel F, Keser G, Ozgen AG, Ynal V, Kabalak T, et al. Thyroid functions in Behçet's disease. Clin Endocrinol (Oxf) 1999;50:406-7.
  12. Akdeniz S, Colak S, Tuzcu AK, Bahceci M, Harman M. Baseline and stimulated thyroid functions in Behçet's disease. J Eur Acad Dermatol Vener